Age-related changes in AMP-activated protein kinase after stroke

• Published in: AGE 2012-02, Vol.34 (1), p.157-168
• Main Authors: Liu, Fudong, Benashski, Sharon E., Persky, Rebecca, Xu, Yan, Li, Jun, McCullough, Louise D.
• Format: Article
• Language: English
• Subjects: Age; Aging; Aging - metabolism; AMP-Activated Protein Kinases - metabolism; Animals; Biomarkers - metabolism; Biomedical and Life Sciences; Body temperature; Brain - enzymology; Cell Biology; Disease Models, Animal; Energy; Geriatrics/Gerontology; Hypothermia; Hypoxia; Ischemia; Kinases; Laboratory animals; Life Sciences; Male; Metabolism; Mice; Molecular Medicine; Predictive Value of Tests; Proteins; Sensitivity and Specificity; Stroke; Stroke - enzymology; Studies; Traumatic brain injury
• ISSN: 0161-9152; 2509-2715; 1574-4647; 2509-2723
• DOI: 10.1007/s11357-011-9214-8

Adenosine monophosphate-activated protein kinase (AMPK) is an evolutionary conserved energy sensor sensitive to changes in cellular AMP/ATP ratio which is activated by phosphorylation (pAMPK). pAMPK levels decrease in peripheral tissues with age, but whether this also occurs in the aged brain, and how this contributes to the ability of the aged brain to cope with ischemic stress is unknown. This study investigated the activation of AMPK and the response to AMPK inhibition after induced stroke in both young and aged male mice. Baseline levels of phosphorylated AMPK were higher in aged brains compared to young mice. Stroke-induced a robust activation of AMPK in young mice, yet this response was muted in the aged brain. Young mice had larger infarct volumes compared with aged animals; however, more severe behavioral deficits and higher mortality were seen in aged mice after stroke. Inhibition of AMPK with Compound C decreased infarct size in young animals, but had no effect in aged mice. Compound C administration led to a reduction in brain ATP levels and induced hypothermia, which led to enhanced neuroprotection in young but not aged mice. This work demonstrates that aging increases baseline brain pAMPK levels; aged mice have a muted stroke-induced pAMPK response; and that AMPK inhibition and hypothermia are less efficacious neuroprotective agents in the aged brain. This has important translational relevance for the development of neuroprotective agents in preclinical models and our understanding of the enhanced metabolic stress experienced by the aged brain.